Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial
Thursday, May 09, 2013
Safety and pharmacokinetics of ALRN-5281, a long-acting growth-hormone-releasing-hormone agonist, established in single-ascending dose study.
Selventa Strengthens Intellectual Property for SysDx™ Approach to Personalized Medicine
Thursday, May 09, 2013
Patent is core to Selventa’s SysDx™ approach to mining and comparing biological data for predicting a patient’s response or non-response to a drug.
Computer Simulations Reveal the Energy Landscape of Ion Channels
Wednesday, May 08, 2013
A team of researchers have investigated the opening and closing mechanisms of these channels: for the first time the full energy landscape of such a large protein could be calculated.
Type 1 Diabetes and Heart Disease Linked by Inflammatory Protein
Wednesday, May 08, 2013
Therapeutic agents that block the protein calprotectin could potentially reverse or slow the progression of atherosclerosis in people with type 1 diabetes.
Unusual Comparison Nets New Sleep Loss Marker
Wednesday, May 08, 2013
Paul Shaw, PhD, a researcher at Washington University School of Medicine in St. Louis, uses what he learns in fruit flies to look for markers of sleep loss in humans.
Proteros and Eisai Announces Successful Completion of Collaboration
Tuesday, May 07, 2013
Proteros and Eisai achieve target in lead discovery project, delivering kinetically optimized lead compounds.
Protein Complex May Play Role in Preventing Many Forms of Cancer, Study Shows
Tuesday, May 07, 2013
Researchers at the Stanford University School of Medicine have identified a group of proteins that are mutated in about one-fifth of all human cancers.
NIH Study Uses Botox to Find New Wrinkle in Brain Communication
Friday, May 03, 2013
Results support new view of molecules important for most nerve cell signaling.
PerkinElmer to Host Revolutionaries for Global Health Summit
Wednesday, May 01, 2013
Company to assemble thought leaders to share pioneering personalized health research and innovations.
|
|
|
|
|
|
